| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |